Harvey I. Pass, MD, discusses some of the challenges of treating patients with mesothelioma
Harvey I. Pass, MD, Stephen E. Banner professor of Thoracic Oncology, vice-chair research, Department of Cardiothoracic Surgery, division chief, General Thoracic Surgery, NYU Langone Medical Center, discusses some of the challenges of treating patients with mesothelioma.
Pass says mesothelioma notoriously affects the elderly and symptoms can be slow to develop and not recognizable, which causes a delay in treatment management. Because of the nature of the disease, Pass says, only about 20% of patients with mesothelioma are good surgical candidates for multimodality treatment.
Pass says it is important to find the disease earlier, when effective therapies may have a chance.
Clinical Pearls
Repotrectinib Elicits an Intracranial Response in ROS1+ Advanced NSCLC
March 25th 2024During a Case-Based Roundtable® event, Christine, Bestvina, MD, discussed the intracranial responses to repotrectinib for patients with ROS1-psotive non–small cell lung cancer in the first article of a 2-part series.
Read More
Behind the FDA Approval of Liso-cel for Relapsed/Refractory CLL/SLL
March 15th 2024In an interview with Targeted Oncology, Tanya Siddiqi, MD, discussed the rationale behind the TRANSCEND CLL 004 study supporting the FDA approval of lisocabtagene maraleucel in chronic lymphocytic leukemia or small lymphocytic lymphoma.
Read More